Literature DB >> 8761361

Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.

M K Parmar, L A Stewart, D G Altman.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8761361      PMCID: PMC2074669          DOI: 10.1038/bjc.1996.392

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  17 in total

1.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Authors:  J P Pignon; R Arriagada; D C Ihde; D H Johnson; M C Perry; R L Souhami; O Brodin; R A Joss; M S Kies; B Lebeau
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

2.  Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.

Authors:  W M Gregory; M A Richards; J S Malpas
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544

Review 3.  Beta-mimetics in preterm labour: an overview of the randomized controlled trials.

Authors:  J F King; A Grant; M J Keirse; I Chalmers
Journal:  Br J Obstet Gynaecol       Date:  1988-03

Review 4.  Identifying relevant studies for systematic reviews.

Authors:  K Dickersin; R Scherer; C Lefebvre
Journal:  BMJ       Date:  1994-11-12

5.  Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group.

Authors:  L A Stewart; M J Clarke
Journal:  Stat Med       Date:  1995-10-15       Impact factor: 2.373

Review 6.  Why sources of heterogeneity in meta-analysis should be investigated.

Authors:  S G Thompson
Journal:  BMJ       Date:  1994-11-19

7.  Completeness of reporting trial results: effect on physicians' willingness to prescribe.

Authors:  M Bobbio; B Demichelis; G Giustetto
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

8.  Meta-analysis of the literature or of individual patient data: is there a difference?

Authors:  L A Stewart; M K Parmar
Journal:  Lancet       Date:  1993-02-13       Impact factor: 79.321

9.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.

Authors:  M L Slevin; L Stubbs; H J Plant; P Wilson; W M Gregory; P J Armes; S M Downer
Journal:  BMJ       Date:  1990-06-02

Review 10.  Statistical aspects of prognostic factor studies in oncology.

Authors:  R Simon; D G Altman
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  6 in total

1.  Evidence based medicine.

Authors:  T Eden
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

Review 2.  Therapeutic trials in childhood ALL: what's their future?

Authors:  O B Eden
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

3.  Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials.

Authors:  R D'Amico; S Pifferi; C Leonetti; V Torri; A Tinazzi; A Liberati
Journal:  BMJ       Date:  1998-04-25

4.  A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?

Authors:  Domenico Ciliberto; Nicoletta Staropoli; Francesca Caglioti; Simona Gualtieri; Lucia Fiorillo; Silvia Chiellino; Antonina Maria De Angelis; Francesco Mendicino; Cirino Botta; Michele Caraglia; Pierfrancesco Tassone; Pierosandro Tagliaferri
Journal:  Cancer Biol Ther       Date:  2015-06-10       Impact factor: 4.742

5.  Role of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials.

Authors:  Ruinian Zheng; Shuai Han; Chongyang Duan; Kexu Chen; Zhijian You; Jun Jia; Shunhuan Lin; Liming Liang; Aixue Liu; Huidong Long; Senming Wang
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.

Authors:  J Sandercock; M K Parmar; V Torri
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.